This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Jan 15;197(2):152-154.

doi: 10.1164/rccm.201709-1957ED.

Breathing Easier: A Well-tolerated Corrector for F508del

David P Nichols¹

Affiliations

PMID: 29048931
DOI: 10.1164/rccm.201709-1957ED

Comment

Breathing Easier: A Well-tolerated Corrector for F508del

David P Nichols. Am J Respir Crit Care Med. 2018.

. 2018 Jan 15;197(2):152-154.

doi: 10.1164/rccm.201709-1957ED.

Author

David P Nichols¹

Affiliation

¹ 1 Seattle Children's Hospital University of Washington School of Medicine Seattle, Washington.

PMID: 29048931
DOI: 10.1164/rccm.201709-1957ED

No abstract available

PubMed Disclaimer

Comment on

Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR.
Donaldson SH, Pilewski JM, Griese M, Cooke J, Viswanathan L, Tullis E, Davies JC, Lekstrom-Himes JA, Wang LT; VX11-661-101 Study Group. Donaldson SH, et al. Am J Respir Crit Care Med. 2018 Jan 15;197(2):214-224. doi: 10.1164/rccm.201704-0717OC. Am J Respir Crit Care Med. 2018. PMID: 28930490 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information